Dominica vs Montserrat: Tuberculosis patients living with HIV receiving antiretroviral therapy
Dominica
0 patients
in 2021
Montserrat
0 patients
in 2019
Dominica rank
141st
Montserrat rank
141st
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Dominica
- Montserrat
How they compare
Dominica currently reports 0 patients against 0 patients in Montserrat, a difference of 0 patients.
The two have swapped places 5 times across 10 shared years of data; in 2009 it was Dominica ahead.
Dominica ranks 141st and Montserrat ranks 141st of 183 countries.
Dominica has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Dominica | Montserrat | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1 patients | 0 patients | 1 patients | Dominica |
| 2010s | 0.3333 patients | 0 patients | 0.3333 patients | Dominica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Dominica or Montserrat?
- Dominica, at 0 patients against 0 patients in Montserrat as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Dominica and Montserrat?
- 0 patients, with Dominica ahead.
- How many years of comparable data are there for Dominica and Montserrat?
- 10 years are reported by both, from 2009 to 2019.
- How do Dominica and Montserrat rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Dominica ranks 141st and Montserrat ranks 141st of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.